Literature DB >> 14652008

TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts.

Mamoru Yoshikawa1, Toshiharu Nakajima, Toshiharu Tsukidate, Kenji Matsumoto, Makoto Iida, Nobuyoshi Otori, Shin-ichi Haruna, Hiroshi Moriyama, Hirohisa Saito.   

Abstract

Two interleukin 13 receptors (IL-13Rs) have been identified as IL-13Ralpha1 and IL-13Ralpha2. IL-13Ralpha1 is composed of a heterodimer consisting of IL-13Ralpha1 and IL-4 receptor alpha (IL-4Ralpha) as a signaling subunit. In contrast, IL-13Ralpha2 is known as a decoy receptor for IL-13. In this study, we investigated the expression of IL-13Rs on human fibroblasts. IL-13Ralpha2 was significantly up-regulated after stimulation with tumor necrosis factor-alpha (TNF-alpha) and/or IL-4. In contrast, IL-13Ralpha1 was constitutively detectable and was not up-regulated. After the induction of IL-13alpha2 by IL-4, STAT6 phosphorylation through IL-13Ralpha1 by IL-13 was inhibited. We also detected large intracellular pools of IL-13Ralpha2 in fibroblasts quantitatively. Furthermore, mobilization of the IL-13Ralpha2 protein stores from the cytoplasm to the cell surface was prevented by an inhibitor of protein transport, brefeldin-A. These results indicate that TNF-alpha and IL-4 synergistically up-regulate the expression of IL-13Ralpha2 decoy receptor on human fibroblasts by inducing gene expression and mobilizing intracellular receptors, and thus may down-regulate the IL-13 signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652008     DOI: 10.1016/j.bbrc.2003.11.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction.

Authors:  Vahe Badalyan; Robert Thompson; Kezia Addo; Lee A Borthwick; Andrew J Fisher; Tatiana Ort; Timothy G Myers; Thomas A Wynn; Thirumalai R Ramalingam
Journal:  J Allergy Clin Immunol       Date:  2014-06-20       Impact factor: 10.793

2.  Alcohol primes the airway for increased interleukin-13 signaling.

Authors:  Patrick O Mitchell; J Spencer Jensen; Jeffrey D Ritzenthaler; Jesse Roman; Andres Pelaez; David M Guidot
Journal:  Alcohol Clin Exp Res       Date:  2008-12-19       Impact factor: 3.455

Review 3.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

4.  A novel and sensitive ELISA reveals that the soluble form of IL-13R-alpha2 is not expressed in plasma of healthy or asthmatic subjects.

Authors:  M O'Toole; H Legault; R Ramsey; T A Wynn; M T Kasaian
Journal:  Clin Exp Allergy       Date:  2008-02-25       Impact factor: 5.018

Review 5.  A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.

Authors:  Martin J Romeo; Rachana Agrawal; Anna Pomés; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

6.  MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts.

Authors:  Xiuxia Zhou; Haizhen Hu; Silvana Balzar; John B Trudeau; Sally E Wenzel
Journal:  J Immunol       Date:  2012-05-09       Impact factor: 5.422

7.  Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia.

Authors:  Claudia Jakubzick; Esther S Choi; Kristin J Carpenter; Steven L Kunkel; Holly Evanoff; Fernando J Martinez; Kevin R Flaherty; Galen B Toews; Thomas V Colby; William D Travis; Bharat H Joshi; Raj K Puri; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

8.  Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts.

Authors:  Loka R Penke; Hideyasu Ouchi; Jennifer M Speth; Njira Lugogo; Yvonne J Huang; Steven K Huang; Marc Peters-Golden
Journal:  Sci Rep       Date:  2020-01-23       Impact factor: 4.379

9.  Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.

Authors:  Bram Verstockt; Sare Verstockt; Brecht Creyns; Sophie Tops; Gert Van Assche; Ann Gils; Jan L Ceuppens; Séverine Vermeire; Marc Ferrante; Christine Breynaert
Journal:  Aliment Pharmacol Ther       Date:  2019-01-20       Impact factor: 8.171

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.